| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC38099-1mg |
|
5843-65-2 |
Higenamine - Glpbio |
0 | 需詢價 | C16H17NO3 | |
| GC38098-20mg |
|
58436-28-5 |
Dihydroresveratrol - Glpbio |
0 | 需詢價 | C14H14O3 | |
| GC38098-10mg |
|
58436-28-5 |
Dihydroresveratrol - Glpbio |
0 | 需詢價 | C14H14O3 | |
| GC38098-5mg |
|
58436-28-5 |
Dihydroresveratrol - Glpbio |
0 | 需詢價 | C14H14O3 | |
| GC38098-1mg |
|
58436-28-5 |
Dihydroresveratrol - Glpbio |
0 | 需詢價 | C14H14O3 | |
| GC38097-20mg |
|
23458-02-8 |
Decursinol - Glpbio |
0 | 需詢價 | C14H14O4 | |
| GC38097-10mg |
|
23458-02-8 |
Decursinol - Glpbio |
0 | 需詢價 | C14H14O4 | |
| GC38097-5mg |
|
23458-02-8 |
Decursinol - Glpbio |
0 | 需詢價 | C14H14O4 | |
| GC38097-1mg |
|
23458-02-8 |
Decursinol - Glpbio |
0 | 需詢價 | C14H14O4 | |
| GC38095-100mg |
|
2022182-58-5 |
Thalidomide-O-amido-C3-NH2 (TFA) - Glpbio |
0 | 需詢價 | C20H21F3N4O8 | |
| GC38095-50mg |
|
2022182-58-5 |
Thalidomide-O-amido-C3-NH2 (TFA) - Glpbio |
0 | 需詢價 | C20H21F3N4O8 | |
| GC38095-10mg |
|
2022182-58-5 |
Thalidomide-O-amido-C3-NH2 (TFA) - Glpbio |
0 | 需詢價 | C20H21F3N4O8 | |
| GC38095-5mg |
|
2022182-58-5 |
Thalidomide-O-amido-C3-NH2 (TFA) - Glpbio |
0 | 需詢價 | C20H21F3N4O8 | |
| GC38095-10mM (in 1mL DMSO) |
|
2022182-58-5 |
Thalidomide-O-amido-C3-NH2 (TFA) - Glpbio |
0 | 需詢價 | C20H21F3N4O8 | |
| GC38094-10mg |
|
93675-88-8 |
Forsythoside E - Glpbio |
0 | 需詢價 | C20H30O12 | |
| GC38094-5mg |
|
93675-88-8 |
Forsythoside E - Glpbio |
0 | 需詢價 | C20H30O12 | |
| GC38094-1mg |
|
93675-88-8 |
Forsythoside E - Glpbio |
0 | 需詢價 | C20H30O12 | |
| GC38093-10mg |
|
20516-23-8 |
(+)-Peusedanol - Glpbio |
0 | 需詢價 | C14H16O5 | |
| GC38093-5mg |
|
20516-23-8 |
(+)-Peusedanol - Glpbio |
0 | 需詢價 | C14H16O5 | |
| GC38093-1mg |
|
20516-23-8 |
(+)-Peusedanol - Glpbio |
0 | 需詢價 | C14H16O5 | |
小泰
|
010-60710855
|